|
|
Volumn 4, Issue 11, 2005, Pages 872-
|
|
Study shows newer schizophrenia treatments no more effective than old
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ATYPICAL ANTIPSYCHOTIC AGENT;
CLOZAPINE;
NEUROLEPTIC AGENT;
OLANZAPINE;
PERPHENAZINE;
QUETIAPINE;
RISPERIDONE;
ZIPRASIDONE;
AGRANULOCYTOSIS;
BODY WEIGHT DISORDER;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG SAFETY;
DRUG SCREENING;
DRUG SELECTIVITY;
HUMAN;
METABOLIC DISORDER;
NOTE;
PRESCRIPTION;
PRIORITY JOURNAL;
SCHIZOPHRENIA;
WEIGHT GAIN;
ANIMALS;
ANTIPSYCHOTIC AGENTS;
CLINICAL TRIALS;
RECEPTORS, DOPAMINE;
RECEPTORS, SEROTONIN;
SCHIZOPHRENIA;
TREATMENT OUTCOME;
|
|
EID: 27844478255
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd1896 Document Type: Note |
|
Times cited : (1)
|
|
References (0)
|